| Dr Richard G Schwartz, MD | |
|
1500 N Dixie Hwy, Ste 304, West Palm Beach, FL 33401-2717 | |
| (561) 833-4022 | |
| (561) 833-4180 |
| Full Name | Dr Richard G Schwartz |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 51 Years |
| Location | 1500 N Dixie Hwy, West Palm Beach, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326041476 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | ME0034767 (Florida) | Primary |
| Entity Name | Richard G. Schwartz, M.d.,p.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407166408 PECOS PAC ID: 5890979108 Enrollment ID: O20110412000283 |
News Archive
The continually rising health care costs in Germany require cost intelligent innovations at the intersecting frontiers of scientific disciplines.
In the quest to find the biological route of drug addiction, research at Cambridge University, UK, is revealing what makes some people more vulnerable than others. Speaking at Europe's major neuroscience conference in Geneva, Professor Barry Everitt described what they now believe causes the switch from occasional, 'recreational' use to a compulsive habit.
OrbiMed, a leading investment management firm focused on the healthcare sector, is pleased to announce the launch of its next venture capital fund, Caduceus Private Investments IV, LP, with $550 million in limited partner commitments. Approximately 80% of the new fund's capital is from returning investors, and the fund's partners include some of the largest pension plans, endowments, foundations, and sovereign funds globally.
A new review highlights new developments in understanding the health effects of silica, and calls for action to reduce illness and death from silica exposure at work, including stronger regulations, heightened awareness and prevention, and increased attention to early detection of silicosis and lung cancer using low dose CT scanning.
BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it has acquired GenCell Biosystems, a privately-held Irish biotech company that has developed proprietary technologies that address key biological analysis protocols – from library preparation of Next Generation Sequencing (NGS) to genotyping for agricultural applications.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard G Schwartz, MD 1500 N Dixie Hwy, Ste 304, West Palm Beach, FL 33401-2717 Ph: (561) 833-4022 | Dr Richard G Schwartz, MD 1500 N Dixie Hwy, Ste 304, West Palm Beach, FL 33401-2717 Ph: (561) 833-4022 |
News Archive
The continually rising health care costs in Germany require cost intelligent innovations at the intersecting frontiers of scientific disciplines.
In the quest to find the biological route of drug addiction, research at Cambridge University, UK, is revealing what makes some people more vulnerable than others. Speaking at Europe's major neuroscience conference in Geneva, Professor Barry Everitt described what they now believe causes the switch from occasional, 'recreational' use to a compulsive habit.
OrbiMed, a leading investment management firm focused on the healthcare sector, is pleased to announce the launch of its next venture capital fund, Caduceus Private Investments IV, LP, with $550 million in limited partner commitments. Approximately 80% of the new fund's capital is from returning investors, and the fund's partners include some of the largest pension plans, endowments, foundations, and sovereign funds globally.
A new review highlights new developments in understanding the health effects of silica, and calls for action to reduce illness and death from silica exposure at work, including stronger regulations, heightened awareness and prevention, and increased attention to early detection of silicosis and lung cancer using low dose CT scanning.
BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it has acquired GenCell Biosystems, a privately-held Irish biotech company that has developed proprietary technologies that address key biological analysis protocols – from library preparation of Next Generation Sequencing (NGS) to genotyping for agricultural applications.
› Verified 4 days ago
Dr. Daniel L Kapp, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 N Dixie Hwy, Ste 304, West Palm Beach, FL 33401 Phone: 561-833-4022 Fax: 561-833-4180 | |
Dr. Roop Monica Gill, B.M. MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1717 N Flagler Dr Ste 1, West Palm Beach, FL 33407 Phone: 561-388-9571 | |
Michael Frederick, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 101 N Clematis St, West Palm Beach, FL 33401 Phone: 561-672-0212 | |
Jana Kimberly Rasmussen, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1717 N Flagler Dr, Suite 1, West Palm Beach, FL 33407 Phone: 561-833-6688 Fax: 561-655-3609 | |
Jeffrey V Stein, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1500 N Dixie Hwy, Suite 304, West Palm Beach, FL 33401 Phone: 561-833-4022 | |
Ravinder S. Jarial, D.O. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 410 Evernia St Ste 109, West Palm Beach, FL 33401 Phone: 561-249-0390 Fax: 561-249-0421 |